Purple Biotech (XTAE:PPBT) EV-to-EBITDA : 0.02 (As of Apr. 26, 2024)

View and export this data going back to 1978. Start your Free Trial

What is Purple Biotech EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Purple Biotech's enterprise value is ₪-1.42 Mil. Purple Biotech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-75.04 Mil. Therefore, Purple Biotech's EV-to-EBITDA for today is 0.02.

The historical rank and industry rank for Purple Biotech's EV-to-EBITDA or its related term are showing as below:

XTAE:PPBT' s EV-to-EBITDA Range Over the Past 10 Years
Min: -3.02 Med: -0.57 Max: 0.54
Current: 0.02

During the past 11 years, the highest EV-to-EBITDA of Purple Biotech was 0.54. The lowest was -3.02. And the median was -0.57.

XTAE:PPBT's EV-to-EBITDA is ranked better than
97.23% of 470 companies
in the Biotechnology industry
Industry Median: 9.14 vs XTAE:PPBT: 0.02

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-04-26), Purple Biotech's stock price is ₪0.213. Purple Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was ₪-0.346. Therefore, Purple Biotech's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.

Purple Biotech EV-to-EBITDA Historical Data

The historical data trend for Purple Biotech's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Purple Biotech EV-to-EBITDA Chart

Purple Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBITDA

Get a 7-Day Free Trial

-1.51

-0.01

-0.57

0.30

-0.32

Purple Biotech Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
EV-to-EBITDA	Get a 7-Day Free Trial															0.30	-0.60	-0.63	-0.41	-0.32

Competitive Comparison of Purple Biotech's EV-to-EBITDA

For the Biotechnology subindustry, Purple Biotech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Purple Biotech's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Purple Biotech's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Purple Biotech's EV-to-EBITDA falls into.

Purple Biotech EV-to-EBITDA Calculation

Purple Biotech's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA	=	Enterprise Value (Today)	/	EBITDA (TTM)
	=	-1.418	/	-75.037
	=	0.02

Purple Biotech's current Enterprise Value is ₪-1.42 Mil.
Purple Biotech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-75.04 Mil.

Purple Biotech (XTAE:PPBT) EV-to-EBITDA Explanation

Purple Biotech's PE Ratio for today is calculated as:

PE Ratio	=	Share Price (Today)	/	Earnings per Share (Diluted) (TTM)
	=	0.213	/	-0.346
	=	At Loss

Purple Biotech's share price for today is ₪0.213.
Purple Biotech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪-0.346.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?

Purple Biotech EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Purple Biotech's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Purple Biotech (XTAE:PPBT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Purple Biotech Ltd (XTAE:PPBT) » Definitions » EV-to-EBITDA

Comparable Companies

Traded in Other Exchanges

PPBT:USA 1YI1:Germany

Address

4 Oppenheimer Street, Science Park, Rehovot, ISR, 7670104

Website

https://www.purple-biotech.com

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.